Companies Dominating the Ophthalmoscope Landscape
- Medline Industries, LP
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eli Lilly and Company
- Bausch & Lomb Incorporated
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Sanofi-aventis Groupe
- Abbott Laboratories
- Merck & Co., Inc.
- Siemens Healthcare GmbH
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of ophthalmoscope is evaluated at USD 274.68 million.
The ophthalmoscope market size was valued at USD 266.16 million in 2024 and is expected to reach USD 443.18 million by 2037, registering around 4% CAGR during the forecast period i.e., between 2025-2037. Rising cases of ocular diseases such as glaucoma, corneal opacification, and others will drive the market growth.
North America industry is anticipated to account for largest revenue share of 37% by 2037, impelled by growing health awareness in the region.
The major players in the market are Medline Industries, LP, Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc.
